Wang Jian,Wang Jianlin,Yu Jingping,et al.Clinical significance of continuous detection of VEGF in patients undergoing chemoradiotherapy for esophageal carcinoma[J].Chinese Journal of Radiological Medicine and Protection,2016,36(4):278-282
Clinical significance of continuous detection of VEGF in patients undergoing chemoradiotherapy for esophageal carcinoma
Received:January 04, 2016  
DOI:10.3760/cma.j.issn.0254-5098.2016.04.009
KeyWords:Esophageal carcinoma  Chemoradiotherapy  Vascular endothelial growth factor  Prognosis
FundProject:江苏省卫生厅指导性科研项目(Z201220)
Author NameAffiliationE-mail
Wang Jian Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochou University, Changzhou 213003, China  
Wang Jianlin Department of Radiotherapy, Changzhou Second People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China  
Yu Jingping Department of Radiotherapy, Changzhou Second People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China  
Sun Zhiqiang Department of Radiotherapy, Changzhou Second People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China  
Sun Wei Department of Radiotherapy, Changzhou Second People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China  
Nie Bin Department of Radiotherapy, Changzhou Second People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China  
Ni Xinchu Department of Radiotherapy, Changzhou Second People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China  
Sun Suping Department of Radiotherapy, Changzhou Second People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China  
Wu Changping Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochou University, Changzhou 213003, China newwcp@163.com 
Hits: 4065
Download times: 2948
Abstract::
      Objective To observe the serum vascular endothelial growth factor(VEGF) change, in order to explore its correlation with the prognosis of patients with esophageal carcinoma treated with chemoradiotherapy. Methods Seventy patients with esophageal carcinoma who were treated with radiotherapy including fifty-three patients with concurrent chemotherapy were enrolled. Serum levels of VEGF were detected before, during(per week) and after radiotherapy by enzyme-linked immunoabsorbent assay (ELISA) and accordingly divided into three groups:rising group,stable group and declining group. Serum VEGF level of 30 healthy subjects served as the control. Results For all patients,the 1-year overall survival(OS) rate and 1-year progression free survival(PFS) rate were 55.7% and 51.4%,respectively. The median values of OS and PFS were 13.4 and 12.5 months, respectively. Thirteen patients were recurrent. Compared with baseline level, the VEGF decreased with significant differences during radiotherapy(F=6.806,P=0.001). The VEGF levels before,during(per week) and after radiotherapy were significantly higher than control group(t=2.165-3.896,P<0.05).There were statistical differences of 1-year OS rate and 1-year PFS rate among different VEGF changing groups(rising group,stable group and declining group)(χ2=6.811, 6.602,P<0.05). However, the local control(LC)rate of the above three groups showed no obvious difference(P>0.05). The baseline VEGF level(before radiotherapy) had no influence on OS,PFS or LC(r=-0.033,-0.056,0.090,P>0.05).VEGF rised mostly in the second,third week during radiotherapy or one week after radiotherapy for nineteen VEGF rising patients. Conclusions The serum VEGF change during chemoradiotherapy could predict the prognosis of patients with esophageal carcinoma. To monitor the VEGF levels in the second, third week during radiotherapy or one week after radiotherapy might have important value on individualized treatment for esophageal carcinoma patients.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:11565301  On-line:0

v
Scan QR Code
&et=3C06DB566315F8DC564481D11FAD77E6C582C73A8417CBC4E032533DAEFE90C223D9DA54B8BC0C349EF8DB249AD9BCAF00EF888833AE3892E5F3C6821CC1B51D36907157BE2470664D05A56CB312971164452B8B9B93D50E2AEFCA76C729D629C3994E155384A50E8D2158AA18FA0BF9365D4C857284AB14&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9F915C6F01DE79C5&aid=28B2676AB082C1DCA62B54222C3DC35A&vid=&iid=E158A972A605785F&sid=B4E8EA49DAAEB84F&eid=4133DDB79B497495&fileno=20160409&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9F915C6F01DE79C5"; var my_aid="28B2676AB082C1DCA62B54222C3DC35A";